AGP Executive Report
Last update: an hour agoOutbreak Watch: Chinese health authorities reported a plague death following a suspected case linked to Russia. Medical Tourism: Hainan’s Boao Lecheng pilot zone logged 863,500 medical visits from January to September, up 84.6% year on year, as it draws more overseas patients. Climate and Health: Heat waves were linked to 19,338 deaths in China in 2025—70% above the 1986–2005 annual average. Separately, research suggests China’s tighter PM₂.₅ limit could prevent substantial numbers of deaths. Drug Development: Boehringer Ingelheim struck a deal with Sino Biopharm covering six cancer programs, with potential payments of up to US$7 billion. Hinova also licensed an experimental autoimmune drug to Evommune in a deal worth up to US$1.1 billion. New Treatments: At the import expo, Bayer is showcasing nearly 30 innovations, including newly approved therapies for stroke-risk reduction and HER2-mutant lung cancer.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
